# Trastuzumab Emtansine (T-DM1) in Patients with Previously Treated HER2-Overexpressing Metastatic Non–Small Cell Lung Cancer: Efficacy, Safety, and Biomarkers

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/trastuzumab-emtansine-t-dm1-in-patients-with-previously-treated-her2/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Solange Peters,Rolf A. Stahel,Lukas Bubendorf,Philip Bonomi,Augusto Villegas,Dariusz M. Kowalski,Christina S. Baik,Dolores Isla,Javier de Castro,Pilar Garrido,Achim Rittmeyer,Marcello Tiseo,Christoph Meyenberg,Sanne de Haas,Lisa H. Lam,Michael W. Lu,Thomas E. Stinchcombe |
| Citations | 231 |
| DOI | 10.1158/1078-0432.ccr-18-1590 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://clincancerres.aacrjournals.org/content/clincanres/25/1/64.full.pdf |
| OpenAlex ID | https://openalex.org/W2889957730 |
| PMID | 30206164 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Marcello Tiseo](https://scholariq.org/researchers/marcello-tiseo/)

## Paper journal

- [Clinical Cancer Research](https://scholariq.org/journals/clinical-cancer-research/)

## Paper primary topic

- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

## Paper topics

- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.